Acadian Asset Management
THRX

Acadian Asset Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Acadian Asset Management’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-96,208
Closed -$388K – 1855
2023
Q4 		$388K Sell
96,208
-163,262
-63% -$498K ﹤0.01% 1090
2023
Q3 		$696K Buy
+259,470
New +$1.02M ﹤0.01% 935

Acadian Asset Management's THRX Position: Q1 2024 in Review

Acadian Asset Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 96,208 shares — an estimated $388K sold.

Acadian Asset Management first reported a position in THRX in Q3 2023 and held it in 2 quarters. The position peaked at $696K in Q3 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

  • Acadian Asset Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 96,208 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $388K.
  • Acadian Asset Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Acadian Asset Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $696K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.